Effect of Zinc on Glucose Homeostasis
Part of paid clinical trials in Lancaster, Pennsylvania.
- Sponsor
- University of Maryland, Baltimore
- Study ID
- NCT05835037
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Hyperglycemia
- Prediabetic State
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Zinc Gluconate 30 MG — DRUGParticipants will take one tablet per day (30 mg Zinc gluconate) for 1 year
- Placebo — DRUGParticipants will take one placebo tablet per day for 1 year
Study Details
The purpose of this investigation is to evaluate the impact of zinc supplementation on fasting glucose levels, hemoglobin A1c (HbA1c), and other indices of glucose homeostasis in individuals with prediabetes. The investigators hypothesize that prediabetic subjects receiving zinc will demonstrate a greater decrease in HbA1c and blood glucose compared to prediabetic subjects receiving placebo. Specific Aim: Conduct a prospective, double-blind randomized clinical trial comparing the effects of 12 months of zinc supplementation (zinc gluconate 30 milligram \[mg\] per day) versus placebo on glucose homeostasis. Based upon expected effect size and power calculations, and anticipating a 20% drop-out rate, the investigators will study 200 prediabetic subjects (100 per group) using a 1:1 randomization design. HbA1c, fasting plasma glucose, and other measures will be obtained at 0, 6, and 12 months and will be compared between zinc supplementation and placebo groups.
Key Dates
- Start date
- Feb 16, 2024
- Status verified
- Apr 2026
- Primary completion
- Jul 31, 2028
- Completion
- Jul 31, 2028
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Zinc treatmentResearch subjects administered zinc gluconate for 1 year (one 30 mg tablet per day)
- Placebo Comparator: PlaceboResearch subjects administered placebo for 1 year (1 tablet per day)
Primary Outcome Measure
Zinc-dependent effect on fasting glucose levels at 1 year [ Time Frame: 1 year ]
Central Contacts
- Joshua P Lewis, PhD410-706-5087
- Hilary B Whitlatch, MD443-682-6800
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Amish Research Clinic | Lancaster | Pennsylvania | 17602 |
Find similar trials in Lancaster, PA
Related Studies
- Diabetes Clinical Decision SupportRecruiting · Milton S. Hershey Medical Center · Hershey, Pennsylvania
- Real-time Engagement for Learning to Effectively Control Type 2 DiabetesNot Yet Recruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 DiabetesRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPHASE4 · Recruiting · VA Office of Research and Development · Phoenix, Arizona